doi: 10.1016/j.annemergmed.2023.07.019 [PubMed] 40648766 Looi E, Lawler HM
Ive found that if I discuss the likely mechanism behind their sleep apneaand if its not related to weight, then I explain that Zepbound might not be appropriatethese conversations tend to go well. For those OSA patients who are Zepbound candidates, the medicine can be a game-changer
The more excess weight a man carries, the higher his risk of erectile dysfunction
Given the high prevalence of obesity, this will incur a substantial economic cost to be borne either by the patient or the state
To learn more about these connections, the American Heart Association, a global force changing the future of health of all, is funding seven new scientific research studies to uncover which patients with obesity and cardiovascular disease are most likely to benefit from GLP-1 medications